MixInYeast: A Multicenter Study on Mixed Yeast Infections.
Candida
chrome agar
invasive candidiasis
mix infections
polymicrobial infections
yeast
Journal
Journal of fungi (Basel, Switzerland)
ISSN: 2309-608X
Titre abrégé: J Fungi (Basel)
Pays: Switzerland
ID NLM: 101671827
Informations de publication
Date de publication:
29 Dec 2020
29 Dec 2020
Historique:
received:
20
11
2020
revised:
20
12
2020
accepted:
21
12
2020
entrez:
1
1
2021
pubmed:
2
1
2021
medline:
2
1
2021
Statut:
epublish
Résumé
Invasive candidiasis remains one of the most prevalent systemic mycoses, and several studies have documented the presence of mixed yeast (MY) infections. Here, we describe the epidemiology, clinical, and microbiological characteristics of MY infections causing invasive candidiasis in a multicenter prospective study. Thirty-four centers from 14 countries participated. Samples were collected in each center between April to September 2018, and they were sent to a reference center to confirm identification by sequencing methods and to perform antifungal susceptibility testing, according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST). A total of 6895 yeast cultures were identified and MY occurred in 150 cases (2.2%). Europe accounted for the highest number of centers, with an overall MY rate of 4.2% (118 out of 2840 yeast cultures). Of 122 MY cases, the most frequent combinations were
Identifiants
pubmed: 33383783
pii: jof7010013
doi: 10.3390/jof7010013
pmc: PMC7823447
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Gilead Sciences research and ESCMID study group
ID : NA
Références
Clin Microbiol Infect. 2020 Jul;26(7):833-841
pubmed: 32246995
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S79-S94
pubmed: 30895218
Clin Microbiol Infect. 2008 Apr;14(4):398-405
pubmed: 18190574
Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S612-7
pubmed: 26567278
Transpl Infect Dis. 2016 Dec;18(6):921-931
pubmed: 27643395
Antimicrob Agents Chemother. 2020 Feb 21;64(3):
pubmed: 31871083
Curr Opin Crit Care. 2010 Oct;16(5):445-52
pubmed: 20711075
J Antimicrob Chemother. 2018 Jan 1;73(suppl_1):i4-i13
pubmed: 29304207
Curr Opin Infect Dis. 2014 Dec;27(6):484-92
pubmed: 25304391
Antimicrob Agents Chemother. 2008 Sep;52(9):3092-8
pubmed: 18591282
Med Mycol. 2016 Mar;54(3):256-65
pubmed: 26613703
Diagn Microbiol Infect Dis. 2007 Dec;59(4):401-6
pubmed: 17888612
Clin Infect Dis. 2007 Jun 15;44(12):e109-14
pubmed: 17516389
Diagn Microbiol Infect Dis. 2002 Dec;44(4):353-7
pubmed: 12543540
PLoS Pathog. 2016 Mar 30;12(3):e1005522
pubmed: 27029023
Antimicrob Agents Chemother. 2014;58(3):1529-37
pubmed: 24366741
PLoS One. 2014 Jul 03;9(7):e101510
pubmed: 24991967
Front Microbiol. 2019 Jul 11;10:1585
pubmed: 31354675
Med Mycol. 2018 Aug 1;56(6):770-773
pubmed: 29087478
Clin Microbiol Infect. 2013 Aug;19(8):E343-53
pubmed: 23607326
Mycoses. 2013 Sep;56(5):576-81
pubmed: 23565662
Nat Rev Dis Primers. 2018 May 11;4:18026
pubmed: 29749387
Clin Infect Dis. 2016 Feb 15;62(4):e1-50
pubmed: 26679628
Rev Esp Quimioter. 2019 Aug;32(4):395-397
pubmed: 31327188
J Antimicrob Chemother. 2019 Mar 1;74(3):618-624
pubmed: 30517635
Infection. 2020 Apr;48(2):275-284
pubmed: 32052287
Drugs. 2014 Sep;74(14):1573-85
pubmed: 25255923
Clin Microbiol Infect. 2012 Dec;18 Suppl 7:19-37
pubmed: 23137135